Oliver Lang appointed new CEO of ONE Insurance
mehr
Storys aus Berlin
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
EANS-News: Correction: AGRANA: significant EBIT decrease in 2018|19 financial year
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Berlin, Wien, Stuttgart language: English ...
mehrEANS-News: Correction: AGRANA: significant EBIT decrease in 2018|19 financial year
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Wien, Berlin, Frankfurt, Stuttgart language: English ...
mehrLabTwin Partners With BioRN to Bring Voice-powered Technology Into German Labs
Berlin (ots/PRNewswire) - LabTwin GmbH, the world's first voice and AI-powered digital lab assistant, has joined forces with BioRN Life Science Cluster to expand its offering to the Rhine-Main-Neckar Region in Germany. As part of this collaboration, BioRN members will have access to LabTwin's platform. LabTwin uses machine learning and voice-recognition technologies to ...
mehrEuropean CIVIS Media Prize 2019 / 21 programmes nominated - four decisions already final!
Cologne (ots) - CIVIS Media Prize 2019 - Nominations and first awards! Anti-Semitism and right-wing extremism are the big topics in the CIVIS Competition 2019 - along with migration, integration, flight and asylum. The political climate in Germany and Europe is changing. What is at stake are our fundamental democratic values. Europe's most prestigious media prize for ...
mehrEuropean Alliance of News Agencies (EANA)
8EANA discusses disinformation during Berlin Conference
mehr
EANS-News: AGRANA opens new fruit preparations plant in Changzhou (China) - IMAGE
http://resources.euroadhoc.com/images/2118/5/10276822/Eröffnung_Changzhou.jpg http://resources.euroadhoc.com/images/2118/5/10276822/Eröffnung_Changzhou2.jpg issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Wien, ...
mehrIPChain: New Types of Intangible Assets at the 10th Global IP Exchange in Berlin on March 13, 2019
Moscow (ots/PRNewswire) - The IPChain Association and the Skolkovo Foundation organized a thematic round table dubbed, "New types of intangible assets and their relation to intellectual property", within the Global IP Exchange in the German capital. The event brought together high-profile experts to discuss new ...
mehrEANS-News: AGRANA Beteiligungs-AG / BIOFACH 2019 in Nuremberg: Discover AGRANA with all your senses
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Berlin, Frankfurt, Stuttgart, Wien language: English ...
mehrEANS-News: AGRANA registers significant earnings reduction for first three quarters of 2018|19
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Stuttgart, Wien, Frankfurt, Berlin language: English ...
mehrProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
Berlin (ots/PRNewswire) - Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced today that the company achieved an undisclosed milestone payment from Merus N.V. (Nasdaq: MRUS) based on Merus' grant of an exclusive license to ...
mehrEANS-News: AGRANA and Amalgamated form joint venture for the manufacture of crystalline betaine
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Frankfurt, Stuttgart, Wien, Berlin language: English ...
mehr
Zizoo Rocks the Boat Industry After Closing EUR6.5m Series A Round
Berlin (ots/PRNewswire) - The leading global boat holiday platform, Zizoo, will double its size in 2019 to keep up with the booming demand for sailing experiences Zizoo (https://www.zizoo.com/), the leading global boat holiday platform, today announced it has completed a EUR6.5m Series A financing round. As a result of a successful performance marked by accelerated ...
mehrEANS-News: Rosenbauer International AG / Quarterly results 3/2018
issuer: Rosenbauer International AG Paschingerstrasse 90 A-4060 Leonding phone: +43(0)732 6794 568 FAX: +43(0)732 6794 89 mail: ir@rosenbauer.com WWW: www.rosenbauer.com ISIN: AT0000922554 indexes: WBI stockmarkets: Stuttgart, Wien, Berlin language: English ...
mehrPrimary Care Diabetes Europe (PCDE)
Primary Care Diabetes Europe Issues Call to Action Against Clinical Inertia in the Treatment of Type-2 Diabetes
Ekeren, Belgium (ots/PRNewswire) - Research identifies lack of primary care physician adherence to treatment guidelines among the challenges to optimal care for patients with type-2 diabetes Primary Care Diabetes Europe (PCDE) today issued a call to action (https://www.pcdeurope.org/early-action/) challenging ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Research into new audio experience resonates at Tinguely Museum in Basel
Bern (ots) - Research into new audio experience resonates at Tinguely Museum in Basel A project funded by the Swiss National Science Foundation is investigating the audio phenomena and sound culture associated with radio. As part of this work, an algorithm has been developed to search radio archives using sound-based criteria. Visitors to the "Radiophonic Spaces" ...
mehrGlobal Survey and Documentary Film Expose Emotional Impact of Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S media - Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those impacted by MS Merck, a leading science and ...
mehrPeople With Diabetes May Achieve Improved Glycaemic Control With Tresiba® Versus Glargine U100, Without an Increase in Hypoglycaemia
Berlin (ots/PRNewswire) - According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved glycaemic control (HbA1c) with Tresiba® (insulin degludec) versus insulin glargine U100, without an increase in hypoglycaemia (potentially dangerous low blood ...
mehr
Ryzodeg® Offers a Simpler Solution With Once-Daily Dosing and Reduced Risk of Nocturnal Hypoglycaemia vs Insulin Glargine U100 Plus Insulin Aspart
Berlin (ots/PRNewswire) - When treated with once-daily Ryzodeg®, people with type 2 diabetes achieved similar blood sugar control with half the number of daily injections, significantly lower total daily insulin dose and significantly reduced risk of nocturnal hypoglycaemia in the Step by Step trial compared with ...
mehrAddressing Social and Cultural Drivers of Type 2 Diabetes is Key to Its Treatment and Prevention
Berlin (ots/PRNewswire) - New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors.[1] Researchers linked factors such as food traditions and traditional gender roles to increasing vulnerability to diabetes in cities[1], where three-quarters ...
mehrVifor Pharma Wins 2018 Pharma 4.0 Award for Implementation of Augmented Reality System
Zurich (ots/PRNewswire) - Vifor Pharma Group today announced that the company and partner Goodly Innovations were awarded the 2018 Pharma 4.0 Award for the innovation of the year in manufacturing execution systems in the pharma industry. Presented on 24 September in Berlin, the purpose of the Pharma 4.0 Award is to recognise outstanding implementation in manufacturing ...
mehrEIT Digital at the Heart of Europe's Digital Innovation Priorities
Brussels (ots/PRNewswire) - With activities focused on Digital Infrastructure (data science, machine learning, cybersecurity and next generation networks), Digital Industry, Digital Wellbeing, Digital Cities and Digital Finance, the results and impact of EIT Digital are at the heart of the priorities, recently identified by the European Commission and national ...
mehrDGAP-News: EDAG Engineering Group AG: Dr. Philippe A. Weber elected interim Chairman of the Board, Extraordinary General Meeting on August 21th
DGAP-News: EDAG Engineering Group AG / Key word(s): Change of Personnel EDAG Engineering Group AG: Dr. Philippe A. Weber elected interim Chairman of the Board, Extraordinary General Meeting on August 21th 26.07.2018 / 10:13 The issuer is solely responsible for the content of this announcement. ...
mehrDGAP-News: Terra Sola Group AG: EGM
DGAP-News: Terra Sola Group AG / Key word(s): AGM/EGM Terra Sola Group AG: EGM 25.07.2018 / 11:39 The issuer is solely responsible for the content of this announcement. 707741 25.07.2018 ...
mehr
EANS-News: AGRANA discloses details of 1:4 share split resolution
issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT0000603709 indexes: WBI stockmarkets: Frankfurt, Berlin, Wien, Stuttgart language: English ...
mehrDGAP-News: BB Biotech shares hold steady in the second quarter
DGAP-News: BB BIOTECH AG / Key word(s): Half Year Results BB Biotech shares hold steady in the second quarter (news with additional features) 20.07.2018 / 07:00 The issuer is solely responsible for the content of this announcement. Media release as of July 20, 2018 Interim report of BB Biotech AG as of June 30, 2018 BB Biotech shares hold steady in the second quarter - Substantial portfolio adjustments, new investments ...
mehrDGAP-Adhoc: EDAG Engineering Group AG: Changes in the Board of Directors
DGAP-Ad-hoc: EDAG Engineering Group AG / Key word(s): Change of Personnel EDAG Engineering Group AG: Changes in the Board of Directors 18-Jul-2018 / 16:12 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this ...
mehrDGAP-Adhoc: EDAG Engineering Group AG: Changes in the board
DGAP-Ad-hoc: EDAG Engineering Group AG / Key word(s): Change of Personnel EDAG Engineering Group AG: Changes in the board 18-Jul-2018 / 11:31 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. 705711 18-Jul-2018 CET/CEST ...
mehrDGAP-News: EDAG Engineering Group AG: EDAG reaches agreement with Zielpuls on essential parameters of an acquisition
DGAP-News: EDAG Engineering Group AG / Key word(s): Mergers & Acquisitions EDAG Engineering Group AG: EDAG reaches agreement with Zielpuls on essential parameters of an acquisition 16.07.2018 / 08:30 The issuer is solely responsible for the content of this announcement. 704489 16.07.2018 ...
mehrDGAP-Adhoc: BB Biotech AG reports preliminary results for 1H 2018
DGAP-Ad-hoc: BB BIOTECH AG / Key word(s): Profit Warning/Half Year Results BB Biotech AG reports preliminary results for 1H 2018 12-Jul-2018 / 18:05 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. 703867 12-Jul-2018 CET/CEST ...
mehr
Vorherige12345678910Nächste